188 related articles for article (PubMed ID: 21700680)
1. BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.
De Luca P; Vazquez ES; Moiola CP; Zalazar F; Cotignola J; Gueron G; Gardner K; De Siervi A
Mol Cancer Res; 2011 Aug; 9(8):1078-90. PubMed ID: 21700680
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 and p53 regulate critical prostate cancer pathways.
De Luca P; Moiola CP; Zalazar F; Gardner K; Vazquez ES; De Siervi A
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):233-8. PubMed ID: 23670255
[TBL] [Abstract][Full Text] [Related]
3. Association of HO-1 and BRCA1 Is Critical for the Maintenance of Cellular Homeostasis in Prostate Cancer.
Labanca E; De Luca P; Gueron G; Paez A; Moiola CP; Massillo C; Porretti J; Giudice J; Zalazar F; Navone N; Vazquez E; De Siervi A
Mol Cancer Res; 2015 Nov; 13(11):1455-64. PubMed ID: 26227317
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation.
Fan S; Twu NF; Wang JA; Yuan RQ; Andres J; Goldberg ID; Rosen EM
Int J Cancer; 1998 Aug; 77(4):600-9. PubMed ID: 9679765
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets.
MacLachlan TK; Takimoto R; El-Deiry WS
Mol Cell Biol; 2002 Jun; 22(12):4280-92. PubMed ID: 12024039
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins.
Fan S; Wang JA; Yuan RQ; Ma YX; Meng Q; Erdos MR; Brody LC; Goldberg ID; Rosen EM
Oncogene; 1998 Jun; 16(23):3069-82. PubMed ID: 9662340
[TBL] [Abstract][Full Text] [Related]
7. BRCA1, a 'complex' protein involved in the maintenance of genomic stability.
Savage KI; Harkin DP
FEBS J; 2015 Feb; 282(4):630-46. PubMed ID: 25400280
[TBL] [Abstract][Full Text] [Related]
8. [DNA damage induces BRCA1 distribution alteration in prostate cancer cell lines].
Wang CY; Sun SK; Fu WJ; Song T; Cai W; Gao JP; Hong BF; Wang XX; Wang H
Zhonghua Nan Ke Xue; 2008 Aug; 14(8):685-9. PubMed ID: 18817338
[TBL] [Abstract][Full Text] [Related]
9. Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells.
Yuan R; Fan S; Wang JA; Meng Q; Ma Y; Schreiber D; Goldberg ID; Rosen EM
Prostate; 1999 Jun; 40(1):37-49. PubMed ID: 10344722
[TBL] [Abstract][Full Text] [Related]
10. The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells.
Yao C; Du W; Chen H; Xiao S; Huang L; Chen F
Leuk Lymphoma; 2015 Mar; 56(3):755-62. PubMed ID: 24996439
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.
Patel D; Chaudhary J
Biochem Biophys Res Commun; 2012 May; 422(1):146-51. PubMed ID: 22564737
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
14. ING3 is required for ATM signaling and DNA repair in response to DNA double strand breaks.
Mouche A; Archambeau J; Ricordel C; Chaillot L; Bigot N; Guillaudeux T; Grenon M; Pedeux R
Cell Death Differ; 2019 Nov; 26(11):2344-2357. PubMed ID: 30804473
[TBL] [Abstract][Full Text] [Related]
15. [BRCA1 and genomic stability].
Fan WH; Zhan QM
Ai Zheng; 2003 Mar; 22(3):331-5. PubMed ID: 12654199
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy.
Takada M; Nagai S; Haruta M; Sugino RP; Tozuka K; Takei H; Ohkubo F; Inoue K; Kurosumi M; Miyazaki M; Sato-Otsubo A; Sato Y; Ogawa S; Kaneko Y
Genes Chromosomes Cancer; 2017 May; 56(5):405-420. PubMed ID: 28124401
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment.
Oplustilova L; Wolanin K; Mistrik M; Korinkova G; Simkova D; Bouchal J; Lenobel R; Bartkova J; Lau A; O'Connor MJ; Lukas J; Bartek J
Cell Cycle; 2012 Oct; 11(20):3837-50. PubMed ID: 22983061
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 is required for hMLH1 stabilization following doxorubicin-induced DNA damage.
Romeo F; Falbo L; Di Sanzo M; Misaggi R; Faniello MC; Viglietto G; Cuda G; Costanzo F; Quaresima B
Int J Biochem Cell Biol; 2011 Dec; 43(12):1754-63. PubMed ID: 21864706
[TBL] [Abstract][Full Text] [Related]
20. Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.
Yemelyanov A; Bhalla P; Yang X; Ugolkov A; Iwadate K; Karseladze A; Budunova I
Cell Cycle; 2012 Jan; 11(2):395-406. PubMed ID: 22223138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]